2025 Annual Meeting | C191 - Artificial Intelligence in Clinical Neurology
01:00 PM - 01:10 PM PDT | Speaker |
Introduction
Sachin Kedar, MD, FAAN |
01:10 PM - 01:30 PM PDT | Speaker |
From Data to Predictive Analytics
Deepak Khazanchi, PhD |
01:30 PM - 01:50 PM PDT | Speaker |
Development of an AI Tool in Neurology
Vijaya B. Kolachalama, PhD, FAHA |
01:50 PM - 02:00 PM PDT | Speaker |
Current State of AI/ML in Neurology
Sachin Kedar, MD, FAAN |
02:00 PM - 02:20 PM PDT | Speaker |
Critical Appraisal of AI Tools in Clinical Research
Vijaya B. Kolachalama, PhD, FAHA |
02:20 PM - 02:40 PM PDT | Speaker |
Ethics and Fairness of AI/ML in Medicine
Deepak Khazanchi, PhD |
02:40 PM - 03:00 PM PDT | Q&A |
Discussion and Audience Participation
Sachin Kedar, MD, FAAN, Vijaya B. Kolachalama, PhD, FAHA, Deepak Khazanchi, PhD |
Sachin Kedar, MD, FAAN | Dr. Kedar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Kedar has received intellectual property interests from a discovery or technology relating to health care. |
Vijaya B. Kolachalama, PhD, FAHA | Vijaya B. Kolachalama, PhD, FAHA has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Vijaya B. Kolachalama, PhD, FAHA has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Altoida. Vijaya B. Kolachalama, PhD, FAHA has stock in CogniScreen Inc.. Vijaya B. Kolachalama, PhD, FAHA has stock in deepPath Inc.. |
Deepak Khazanchi, PhD | The institution of Deepak Khazanchi, PhD has received research support from U.S. Army Corp of Engineers. |